Untitled

CanCURE

The Canadian HIV Cure Enterprise (CanCURE) is a research collaboratory focused on studying HIV persistence during antiretroviral therapy and developing strategies towards a sustainable HIV remission. Our innovative scientific program is supported by the Canadian Institutes of Health Research (CIHR).

CanCURE Photo Gallery
1/2

Available Positions

Postdoctoral Fellow

Human Immunodeficiency Virus (HIV)-host interactions governing HIV persistence in different models of humanized mice. Dr. Eric Cohen, Montreal Clinical Research Institute (IRCM, Montreal)

PhD trainee/Postdoc

Immunity during HIV infection, Dr. Cecilia Costiniuk and Mohammad-Ali Jenabian, IR-MUHC, Montreal (2 positions available)

Postdoctoral Fellow 

Immunity during HIV infection Dr. Cecilia Costiniuk, MUHC, McGill, Montreal

Publications

 Abdel-Mohsen et al. Recommendations for measuring HIV reservoir size in cure-directed clinical trials. Nature Med. September 2020 

Gantner et al. Single-cell TCR sequencing reveals phenotypically diverse clonally expanded cells harboring inducible HIV proviruses during ART. Nature Communications. August 2020

 

Zhang et al. Improving HIV Outgrowth by Optimizing Cell-Culture Conditions and Supplementing With all-trans Retinoic Acid. Frontiers in Microbiology. May 2020

Rabezanahary et al. Despite early antiretroviral therapy effector memory and follicular helper CD4 T cells are major reservoirs in visceral lymphoid tissues of SIV-infected macaques. Mucosal Immunol. Nov 2019

©2021 CanCURE

Follow

  • https://twitter.com/cancurehiv
  • White Facebook Icon
  • White YouTube Icon
  • White LinkedIn Icon